Keijo Fukushima Selected Research

EP3 Subtype Prostaglandin E Receptors

1/2022

Identification and Characterization of Human Colorectal Cancer Cluster Predominantly Expressing EP3 Prostanoid Receptor Subtype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keijo Fukushima Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 01/2017
5	Colonic Neoplasms (Colon Cancer) 04/2022 - 01/2017
4	Infections 01/2015 - 10/2012
3	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 06/2019
3	Carcinogenesis 04/2022 - 12/2018
3	Inflammation (Inflammations) 01/2020 - 01/2015
2	Hypoxia (Hypoxemia) 04/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 01/2018
2	Fibrosis (Cirrhosis) 12/2019 - 07/2018
1	Alzheimer Disease (Alzheimer's Disease) 05/2022
1	Neuroblastoma 05/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022
1	Dyslipidemias (Dyslipidemia) 04/2022
1	Hyperalgesia 04/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Iron Deficiencies 01/2020
1	Anemia 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Hypertension (High Blood Pressure) 12/2019
1	Vascular Remodeling 12/2019
1	Myocarditis (Carditis) 11/2019
1	Ovarian Neoplasms (Ovarian Cancer) 03/2019
1	Drug-Related Side Effects and Adverse Reactions 03/2019
1	Neutropenia 03/2019
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2018
1	Heart Arrest (Cardiac Arrest) 12/2017
1	Human Influenza (Influenza) 01/2015
1	Virus Diseases (Viral Diseases) 10/2012
1	Orthomyxoviridae Infections 10/2010
1	Paramyxoviridae Infections (Parainfluenza) 10/2010

Drug/Important Bio-Agent (IBA)

5	Dinoprostone (PGE2)FDA Link 04/2022 - 01/2017
5	ProstaglandinsIBA 04/2022 - 11/2017
3	Pharmaceutical PreparationsIBA 04/2022 - 01/2018
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2022 - 06/2019
2	CytokinesIBA 04/2022 - 01/2015
2	Angiotensin IIIBA 12/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 06/2019 - 01/2018
1	PlasmalogensIBA 05/2022
1	Arachidonic Acid (Vitamin F)IBA 05/2022
1	STAT6 Transcription FactorIBA 04/2022
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 04/2022
1	InterleukinsIBA 04/2022
1	Interleukin-4 (Interleukin 4)IBA 04/2022
1	Interleukin-13IBA 04/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022
1	Simvastatin (Zocor)FDA LinkGeneric 04/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2022
1	Transcription Factor 3IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	EP3 Subtype Prostaglandin E ReceptorsIBA 01/2022
1	Diphenhydramine (Benadryl)FDA LinkGeneric 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	15-ketoprostaglandin E2IBA 01/2020
1	IronIBA 01/2020
1	Proton Pump InhibitorsIBA 01/2020
1	Rubber (Elastica)IBA 12/2019
1	Febuxostat FDA Link 12/2019
1	Uric Acid (Urate)IBA 12/2019
1	Xanthine OxidaseIBA 12/2019
1	Immune Checkpoint InhibitorsIBA 11/2019
1	Carrier Proteins (Binding Protein)IBA 06/2019
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 06/2019
1	Volatile Fatty AcidsIBA 06/2019
1	SodiumIBA 06/2019
1	Butyrates (Butyrate)IBA 06/2019
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 06/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2019
1	LuciferasesIBA 12/2018
1	edoxabanIBA 07/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018
1	Nifedipine (Adalat)FDA LinkGeneric 01/2018
1	nitrosonifedipineIBA 01/2018
1	AntioxidantsIBA 01/2018
1	AminopropionitrileIBA 01/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2017
1	CateninsIBA 11/2017
1	TCF Transcription FactorsIBA 11/2017
1	Alprostadil (Muse)FDA LinkGeneric 11/2017
1	prostaglandin E3 (PGE3)IBA 11/2017
1	15-hydroxyprostaglandin dehydrogenaseIBA 01/2017
1	MW-03IBA 01/2017
1	indoleIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	BTP3-Neu5AcIBA 01/2015
1	Neuraminidase (Sialidase)IBA 01/2015
1	AcidsIBA 01/2015
1	SialyltransferasesIBA 09/2014
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 09/2014
1	Sulfoglycosphingolipids (Sulfatides)IBA 10/2012
1	Monoclonal AntibodiesIBA 10/2012
1	Hydrolyzable TanninsIBA 10/2010
1	strictininIBA 10/2010
1	Antiviral Agents (Antivirals)IBA 10/2010

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2020
1	Length of Stay 12/2017
1	Oral Administration 01/2015